keyword
https://read.qxmd.com/read/38652877/datopotamab-deruxtecan-in-advanced-or-metastatic-hr-her2-and-triple-negative-breast-cancer-results-from-the-phase-i-tropion-pantumor01-study
#1
JOURNAL ARTICLE
Aditya Bardia, Ian E Krop, Takahiro Kogawa, Dejan Juric, Anthony W Tolcher, Erika P Hamilton, Toru Mukohara, Aaron Lisberg, Toshio Shimizu, Alexander I Spira, Junji Tsurutani, Senthil Damodaran, Kyriakos P Papadopoulos, Jonathan Greenberg, Fumiaki Kobayashi, Hong Zebger-Gong, Rie Wong, Yui Kawasaki, Tadakatsu Nakamura, Funda Meric-Bernstam
PURPOSE: Datopotamab deruxtecan (Dato-DXd) is an antibody-drug conjugate consisting of a humanized antitrophoblast cell-surface antigen 2 (TROP2) monoclonal antibody linked to a potent, exatecan-derived topoisomerase I inhibitor payload via a plasma-stable, selectively cleavable linker. PATIENTS AND METHODS: TROPION-PanTumor01 (ClinicalTrials.gov identifier: NCT03401385) is a phase I, dose-escalation, and dose-expansion study evaluating Dato-DXd in patients with previously treated solid tumors...
April 23, 2024: Journal of Clinical Oncology
https://read.qxmd.com/read/38652367/combined-effect-of-pantoprazole-and-mesenchymal-stem-cells-on-experimentally-induced-gastric-ulcer-implication-of-oxidative-stress-inflammation-and-apoptosis-pathways
#2
JOURNAL ARTICLE
Alaa H Sayed, Nadia S Mahmoud, Ola A M Mohawed, Hanaa H Ahmed
Gastric ulcer (GU) is one of the most common diseases of the upper gastrointestinal tract that affects millions of people worldwide. This study aimed to investigate the possible alleviating effect of a combined treatment of pantoprazole (PANTO) and adipose tissue-derived mesenchymal stem cells (ADSCs) in comparison with each treatment alone on the healing process of the experimentally induced GU in rats, and to uncover the involved pathways. Rats were divided into five groups: (1) Control, (2) GU, (3) PANTO, (4) ADSCs and (5) ADSCs + PANTO...
April 23, 2024: Inflammopharmacology
https://read.qxmd.com/read/38651722/-not-available
#3
JOURNAL ARTICLE
Ingvild Kathrin Lokøy, Inga Sofie Bakken, Elisabeth Wik, Ingunn Marie Stefansson
BACKGROUND: Breast cancer in men accounts for around 1 % of all cases of the disease. The study aimed to identify histopathological parameters and selected biomarkers in men with breast cancer. MATERIAL AND METHOD: Retrospective study of archival material from 53 men diagnosed with breast cancer at the department of pathology, Haukeland University Hospital, in the period 1996-2020. The prevalence of the oestrogen receptor (ER), progesterone receptor (PGR) and Human Epidermal Growth Factor (HER2) biomarkers was examined...
April 23, 2024: Tidsskrift for Den Norske Lægeforening: Tidsskrift for Praktisk Medicin, Ny Række
https://read.qxmd.com/read/38651148/a-study-of-high-dose-furmonertinib-in-egfr-exon-20-insertion-mutation-positive-advanced-non-small-cell-lung-cancer
#4
JOURNAL ARTICLE
Song Hu, Hao Ming, Qian He, Ming Ding, Hao Ding, Chong Li
BACKGROUND: The epidermal growth factor receptor (EGFR) ex20ins mutation, as a rare subtype of mutation, has gradually attracted attention. Its heterogeneity is high, its prognosis is extremely poor, and the efficacy of existing traditional treatment plans is limited. In this study, we aimed to evaluate efficacy of high dose furmonertinib as a first-line treatment for EGFR ex20ins-positive NSCLC. METHODS: This is a retrospective, multi-center, non-interventional study...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38650801/the-association-of-the-epidermal-growth-factor-receptor-egfr-immunoexpression-with-prognostic-parameters-in-adenocarcinoma-patients-receiving-neoadjuvant-treatment
#5
JOURNAL ARTICLE
Derya Demir, Murtaza Parvizi, Burcin Pehlivanoglu, Erhan Ergin, Semin Ayhan, Basak Doganavsargil
The epidermal growth factor receptor (EGFR) expression is considered to play an essential role in the pathogenesis of colorectal adenocarcinoma. This study assessed the expression and predictive/prognostic value of EGFR expression in pre-op biopsy and post-op resection specimens in patients receiving neoadjuvant radiotherapy/neoadjuvant chemoradiotherapy (NRT/NCRT). Thirty-four consecutive patients were included in this study. The association between the prognostic features and EGFR immunohistochemical expression was analyzed in pre- (n=34) and post-treatment (n=22) tissue samples in cases with available tissue blocks...
March 2024: Curēus
https://read.qxmd.com/read/38649936/clinical-significance-of-urinary-inflammatory-biomarkers-in-patients-with-iga-nephropathy
#6
JOURNAL ARTICLE
Soo-Young Yoon, Jin Sug Kim, Su Woong Jung, Yang Gyun Kim, Ju-Young Moon, Sang-Ho Lee, Sung-Vin Yim, Hyeon Seok Hwang, Kyunghwan Jeong
BACKGROUND: IgA nephropathy (IgAN) is the most common type of primary glomerulonephritis, although the definitive markers are unknown. We aimed to investigate the clinical significance of urinary cytokines in patients with IgAN. METHODS: From 2009 to 2018, the patients were divided into three groups: IgAN (n = 191), disease control (n = 53), and normal control (n = 76). We used a multiplex enzyme-linked immunosorbent assay to measure 16 selected urinary inflammatory cytokines, evaluated the correlation between clinical and pathological features following regression analysis on progression...
April 22, 2024: BMC Nephrology
https://read.qxmd.com/read/38649851/multiplex-proteomics-identifies-inflammation-related-plasma-biomarkers-for-aging-and-cardio-metabolic-disorders
#7
JOURNAL ARTICLE
Siting Wu, Yulin Li, Xue Zhao, Fu-Dong Shi, Jingshan Chen
BACKGROUND: Cardio-metabolic disorders (CMDs) are common in aging people and are pivotal risk factors for cardiovascular diseases (CVDs). Inflammation is involved in the pathogenesis of CVDs and aging, but the underlying inflammatory molecular phenotypes in CMDs and aging are still unknown. METHOD: We utilized multiple proteomics to detect 368 inflammatory proteins in the plasma of 30 subjects, including healthy young individuals, healthy elderly individuals, and elderly individuals with CMDs, by Proximity Extension Assay technology (PEA, O-link)...
April 22, 2024: Clinical Proteomics
https://read.qxmd.com/read/38649819/key-mrnas-and-lncrnas-of-pituitary-that-affect-the-reproduction-of-fecb%C3%A2-%C3%A2-%C3%A2-small-tail-han-sheep
#8
JOURNAL ARTICLE
Jianqi Yang, Jishun Tang, Xiaoyun He, Ran Di, Xiaosheng Zhang, Jinlong Zhang, Xiaofei Guo, Wenping Hu, Mingxing Chu
BACKGROUND: The pituitary directly regulates the reproductive process through follicle-stimulating hormone (FSH) and luteinizing hormone (LH). Transcriptomic research on the pituitaries of ewes with different FecB (fecundity Booroola) genotypes has shown that some key genes and lncRNAs play an important role in pituitary function and sheep fecundity. Our previous study found that ewes with FecB + + genotypes (without FecB mutation) still had individuals with more than one offspring per birth...
April 22, 2024: BMC Genomics
https://read.qxmd.com/read/38649211/analysis-of-mechanism-of-core-points-in-acupuncture-and-moxibustion-treatment-for-epilepsy-based-on-data-mining
#9
JOURNAL ARTICLE
Yi-Wen Zhang, Guang-Yu Cheng, Xuan Wang, Wei-Ping Cheng
OBJECTIVES: To explore the mechanism of core points in acupuncture and moxibustion treatment for epilepsy by using data mining technique, so as to provide a reference for clinical practice and experimental research. METHODS: The data comes from relevant documents collected from CNKI, Wanfang, SinoMed, VIP, PubMed, Embase, Cochrane Library, EBSCO, Web of Science databases. The selected acupoints were analyzed in descriptive statistics, high-frequency acupoints group and core acupoint prescription...
April 25, 2024: Zhen Ci Yan Jiu, Acupuncture Research
https://read.qxmd.com/read/38648979/antibody-drug-conjugates-in-lung-and-breast-cancer-current-evidence-and-future-directions-a-position-statement-from-the-etop-ibcsg-partners-foundation
#10
REVIEW
S Peters, S Loi, F André, S Chandarlapaty, E Felip, S P Finn, P A Jänne, K M Kerr, E Munzone, A Passaro, M Pérol, E F Smit, C Swanton, G Viale, R A Stahel
Following the approval of the first antibody-drug conjugates (ADCs) in the early 2000s, development has increased dramatically, with 14 ADCs now approved and >100 in clinical development. In lung cancer, trastuzumab deruxtecan (T-DXd) is approved in human epidermal growth factor receptor 2 (HER2)-mutated, unresectable or metastatic non-small cell lung cancer, with ADCs targeting HER3 (patritumab deruxtecan), trophoblast cell-surface antigen 2 (datopotamab deruxtecan and sacituzumab govitecan [SG]) and mesenchymal-epithelial transition factor (telisotuzumab vedotin) in late-stage clinical development...
April 20, 2024: Annals of Oncology: Official Journal of the European Society for Medical Oncology
https://read.qxmd.com/read/38648768/human-blood-serum-counteracts-egfr-her2-targeted-drug-lapatinib-impact-on-squamous-carcinoma-sk-br-3-cell-growth-and-gene-expression
#11
JOURNAL ARTICLE
Nina Shaban, Mikhail Raevskiy, Galina Zakharova, Victoria Shipunova, Sergey Deyev, Maria Suntsova, Maksim Sorokin, Anton Buzdin, Dmitri Kamashev
Lapatinib is a targeted therapeutic inhibiting HER2 and EGFR proteins. It is used for the therapy of HER2-positive breast cancer, although not all the patients respond to it. Using human blood serum samples from 14 female donors (separately taken or combined), we found that human blood serum dramatically abolishes the lapatinib-mediated inhibition of growth of the human breast squamous carcinoma SK-BR-3 cell line. This antagonism between lapatinib and human serum was associated with cancelation of the drug induced G1/S cell cycle transition arrest...
March 2024: Biochemistry. Biokhimii︠a︡
https://read.qxmd.com/read/38648537/molecular-docking-mmgbsa-and-admet-studies-of-phytoconstituents-of-ocimum-gratissimum-on-multiple-breast-cancer-targets
#12
JOURNAL ARTICLE
Basiru Olaitan Ajiboye, Toluwase Hezekiah Fatoki, Precious Ayorinde Akinnusi, Olawale Rasaq Ajuwon, Babatunji Emmanuel Oyinloye, Temitope Olawale Jeje, Olutunmise Victoria Owolabi, Oluwatosin O Ogedengbe, Claudia Genovese
O. gratissimum is one of the most common medicinal plants in every community in Nigeria. This plant has been presumed to be useful in the management of diseases including breast cancer, which is one the commonest cancers affecting women globally. Hence, this study aimed to computationally investigate the phytochemicals present in O. gratissimum by elucidate their binding dynamics against five selected molecular targets of breast cancer and predict their pharmacokinetics properties. Molecular docking, MMGBSA calculation and ADMET prediction were used...
April 22, 2024: Natural Product Research
https://read.qxmd.com/read/38648387/cancer-associated-fibroblast-activation-predicts-progression-metastasis-and-prognosis-of-cutaneous-squamous-cell-carcinoma
#13
JOURNAL ARTICLE
Jaakko S Knuutila, Pilvi Riihilä, Liisa Nissinen, Lauri Heiskanen, Roosa E Kallionpää, Teijo Pellinen, Veli-Matti Kähäri
Cutaneous squamous cell carcinoma (cSCC) is the most common metastatic skin cancer and the metastatic disease is associated with poor prognosis. Cancer-associated fibroblasts (CAFs) promote progression of cancer, but their role in cSCC is largely unknown. We examined the potential of CAF markers in the assessment of metastasis risk and prognosis of primary cSCC. We utilized multiplexed fluorescence immunohistochemistry for profiling CAF landscape in metastatic and non-metastatic primary human cSCCs, in metastases, and in premalignant epidermal lesions...
April 22, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38647165/cost-of-disease-progression-among-us-patients-with-human-epidermal-growth-factor-receptor-2-positive-metastatic-breast-cancer
#14
JOURNAL ARTICLE
Clara Lam, Brandon Diessner, Katherine Andrade, Sydnie Stackland, Leah Park, Sandhya Mehta, Feng Lin, Winghan Jackie Kwong
Aim: The objectives were to investigate the differences in per patient per month (PPPM) healthcare resource utilization (HCRU) and costs among commercially insured and Medicare Advantage patients with human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer (mBC) who experience disease progression in 12 months compared with those who don't investigate the impact of progression timing on cumulative healthcare costs. Patients & methods: This claims-based study included patients diagnosed with mBC between 1 January 2013 and 30 April 2020 and received HER2-targeted therapy...
April 22, 2024: Journal of Comparative Effectiveness Research
https://read.qxmd.com/read/38646491/clinical-significance-of-the-cxcl8-cxcr1-r2-signalling-axis-in-patients-with-invasive-breast-cancer
#15
JOURNAL ARTICLE
Sebastian Stępień, Marta Smycz-Kubańska, Celina Kruszniewska-Rajs, Joanna Magdalena Gola, Jacek Kabut, Paweł Olczyk, Aleksandra Mielczarek-Palacz
The C-X-C motif chemokine ligand 8 (CXCL8)-C-X-C chemokine receptor (CXCR)1/2 signalling axis is among numerous mechanisms which stimulate the immune system to defend against tumour growth and influence the tumour microenvironment to promote tumour growth. This pathway plays an important role in the development of a number of cancers including breast cancer (BC). The aim of the present study was to analyse the levels of the chemokine CXCL8 and its receptors, CXCR1 and CXCR2, in the serum of female patients with invasive BC and to assess the expression of these parameters at the mRNA level, considering molecular subtypes and degrees of cancer malignancy...
June 2024: Oncology Letters
https://read.qxmd.com/read/38646279/bevacizumab-induced-cutaneous-lupus-erythematosus-in-a-patient-with-metastatic-colon-carcinoma-a-case-report
#16
Sethi Ashish, Moses Raj, Eric Zhuang
Bevacizumab, an anti-vascular epidermal growth factor inhibitor, is approved for the treatment of various cancers. Hypertension, gastrointestinal perforation, bleeding manifestations, impaired wound healing, and cerebrovascular accidents are common side effects associated with the monoclonal antibody. Uncommon cutaneous reactions like exfoliative dermatitis associated with bevacizumab have been documented in the medical literature. We present an unusual case of bevacizumab-induced cutaneous lupus in a patient with metastatic colon cancer that started resolving after discontinuing chemotherapy...
March 2024: Curēus
https://read.qxmd.com/read/38646225/the-safety-and-effectiveness-of-bevacizumab-in-metastatic-colorectal-cancer-with-unresectable-metastases-a-real-life-study-from-the-south-of-morocco
#17
JOURNAL ARTICLE
Ghizlane Rais, Farah Boutaagount, Rania Mokfi, Meryem Maskrout, Soundous Bennour, Chaymae Senoussi, Fadoua Rais, Laila Lahlou
Background Colorectal cancer constitutes a significant public health challenge, despite remarkable strides made in the last two decades, particularly in the medical management of metastatic stages. Notable progress has been achieved through targeted therapies such as anti-epidermal growth factor receptors or anti-angiogenic antibodies, as well as advancements in surgical approaches for hepatic metastases. This study seeks to assess the efficacy and safety of bevacizumab plus chemotherapy in individuals with metastatic colorectal cancer...
March 2024: Curēus
https://read.qxmd.com/read/38646145/molecular-diversity-in-isocitrate-dehydrogenase-wild-type-glioblastoma
#18
REVIEW
Jawad Fares, Yizhou Wan, Richard Mair, Stephen J Price
In the dynamic landscape of glioblastoma, the 2021 World Health Organization Classification of Central Nervous System tumours endeavoured to establish biological homogeneity, yet isocitrate dehydrogenase-wild-type (IDH-wt) glioblastoma persists as a tapestry of clinical and molecular diversity. Intertumoural heterogeneity in IDH-wt glioblastoma presents a formidable challenge in treatment strategies. Recent strides in genetics and molecular biology have enhanced diagnostic precision, revealing distinct subtypes and invasive patterns that influence survival in patients with IDH-wt glioblastoma...
2024: Brain communications
https://read.qxmd.com/read/38645986/a-novel-network-pharmacology-strategy-based-on-the-universal-effectiveness-common-mechanism-of-medical-herbs-uncovers-therapeutic-targets-in-traumatic-brain-injury
#19
JOURNAL ARTICLE
Zhe Yu, Ruoqi Ding, Qiuju Yan, Menghan Cheng, Teng Li, Fei Zheng, Lin Zhu, Yang Wang, Tao Tang, En Hu
PURPOSE: Many herbs can promote neurological recovery following traumatic brain injury (TBI). There must lie a shared mechanism behind the common effectiveness. We aimed to explore the key therapeutic targets for TBI based on the common effectiveness of the medicinal plants. MATERIAL AND METHODS: The TBI-effective herbs were retrieved from the literature as imputes of network pharmacology. Then, the active ingredients in at least two herbs were screened out as common components...
2024: Drug Design, Development and Therapy
https://read.qxmd.com/read/38645591/floating-electrode-dielectric-barrier-discharge-based-plasma-promotes-skin-regeneration-in-a-full-thickness-skin-defect-mouse-model
#20
JOURNAL ARTICLE
Mohana Devi Subramaniam, Joon Suk Bae, Jiwon Son, Laurensia Danis Anggradita, Min-Kyu Kim, Min Yong Lee, Seokyoon Jang, Kwangok Choi, Justine C Lee, Seung Min Nam, Yongsung Hwang
Wound healing involves a complex and dynamic interplay among various cell types, cytokines, and growth factors. Macrophages and transforming growth factor-β1 (TGF-β1) play an essential role in different phases of wound healing. Cold atmospheric plasma has a wide range of applications in the treatment of chronic wounds. Hence, we aimed to investigate the safety and efficacy of a custom-made plasma device in a full-thickness skin defect mouse model. Here, we investigated the wound tissue on days 6 and 12 using histology, qPCR, and western blotting...
May 2024: Biomedical Engineering Letters
keyword
keyword
78610
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.